CALDERWOOD & HARKNESS LLP 7 Times Square New York, NY 10036
MEMORANDUM — PRIVILEGED & CONFIDENTIAL ATTORNEY WORK PRODUCT
THIS MEMORANDUM IS PROTECTED BY THE ATTORNEY-CLIENT PRIVILEGE AND THE ATTORNEY WORK PRODUCT DOCTRINE. IT IS PREPARED BY COUNSEL FOR THE PURPOSE OF PROVIDING LEGAL ADVICE AND IN ANTICIPATION OF LITIGATION OR REGULATORY PROCEEDINGS. DO NOT DISTRIBUTE WITHOUT THE EXPRESS AUTHORIZATION OF THE RESPONSIBLE PARTNER.
Right-click to update Table of Contents
I. Purpose of This Memorandum
The purpose of this memorandum is to document the filing, on March 28, 2025, of the Premerger Notification and Report Form (the "HSR Notification Form" or "Filing") pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (15 U.S.C. § 18a) (the "HSR Act"), and the implementing rules promulgated thereunder by the Federal Trade Commission (16 C.F.R. Parts 801–803) (the "HSR Rules"), in connection with the proposed acquisition of all outstanding voting securities of Luminex Systems Holdings Inc. ("Luminex Holdings" or the "Company") by Ardent Apex Holdings Inc. ("Ardent Apex" or the "Acquirer"), an indirect wholly owned subsidiary of Ardent Capital Partners III LP ("Ardent Fund III" or the "Client"), through a reverse triangular merger (the "Transaction" or the "Proposed Acquisition").
This memorandum is intended to serve the following functions:
1. Filing Record. Memorialize the key filing details, including the filing date, HSR Transaction Number, filing fee calculation and payment, filing persons, notification form content, and initial waiting period calculation.
2. Transaction Description. Summarize the structure, consideration, parties, and key terms of the Proposed Acquisition as relevant to the HSR filing and associated antitrust analysis.
3. Competitive Analysis. Set forth the relevant market definitions, market share estimates, competitive overlap analysis, and Herfindahl-Hirschman Index ("HHI") concentration analysis underlying the engagement team's assessment of the likely regulatory posture of the reviewing agency.
4. Second Request Anticipation. Preserve a contemporaneous record of the antitrust analysis supporting the engagement team's expectation that the Federal Trade Commission (the "FTC") is likely to issue a Request for Additional Information and Documentary Material (a "Second Request") prior to the expiration of the initial 30-day waiting period, and to cross-reference the separately filed Second Request Preparation Memorandum and related work product.
5. Coordination Record. Document the advisory team, inter-firm coordination arrangements, and parallel regulatory filings for the Transaction.
6. Privilege Preservation. Ensure that all internal memoranda, analyses, and communications regarding the HSR filing, competitive analysis, Second Request preparation, and remedy scenarios are properly documented as having been prepared by and at the direction of counsel and are protected by the attorney-client privilege and the attorney work product doctrine.
This memorandum will be supplemented as material developments occur during the regulatory review process.
II. Transaction Summary
A. Parties to the Transaction
1. Acquiring Person (Ultimate Parent Entity)
The acquiring person for purposes of the HSR Act is Ardent Capital Partners III LP ("Ardent Fund III"), a Delaware limited partnership with its principal offices at 399 Park Avenue, 42nd Floor, New York, NY 10022. Ardent Fund III's employer identification number is 87-3941026.
Ardent Fund III is managed by its general partner, Ardent Capital GP III LLC, a Delaware limited liability company. The co-founders and managing partners of the Ardent Capital platform are Theodore ("Ted") Hargrove and Victoria Langford, both of whom serve as managing members of Ardent Capital GP III LLC and sit on the fund's investment committee.
Ardent Fund III is a 2023 vintage fund with total committed capital of approximately $12.5 billion. The Ardent Capital platform manages total assets under management of approximately $31.4 billion across four flagship private equity funds (Funds I through IV, with Fund IV currently in fundraising) and related co-investment vehicles. The firm's investment strategy is focused on growth and buyout investments in enterprise technology, financial infrastructure, and healthcare IT sectors.
For purposes of the HSR filing, Ardent Fund III is designated as the ultimate parent entity ("UPE") of the acquiring person, and all entities controlled by Ardent Fund III — including Ardent Capital GP III LLC, Ardent Apex Holdings Inc., Ardent Apex Merger Sub Inc., and all portfolio companies held through Fund III and its affiliated funds sharing common control — are included within the acquiring person's filing. As discussed in greater detail in Section V below, this includes Vectis Solutions LLC, a portfolio company of Ardent Capital Partners II LP ("Ardent Fund II"), which is controlled by a common general partner and overlapping investment committee, and which operates in a market overlapping with Luminex Holdings.
2. Acquired Person (Ultimate Parent Entity / Filing Person)
The acquired person for purposes of the HSR Act is Luminex Systems Holdings Inc. ("Luminex Holdings" or the "Company"), a Delaware corporation with its principal offices at 2100 Reston Gateway Drive, Suite 800, Reston, VA 20191. Luminex Holdings' employer identification number is 86-2547193. The Company was incorporated under the laws of the State of Delaware on June 14, 2021.
Luminex Holdings serves as the intermediate U.S. holding company for Luminex Systems AG, a Swiss corporation (Aktiengesellschaft) organized under the laws of the Canton of Glenrock Assurance, Switzerland (Commercial Register No. CHE-284.391.057), and for the Company's worldwide operations. Luminex Holdings was formed in connection with a 2021 corporate reorganization of the Luminex group's holding structure, pursuant to which Luminex Systems AG and its global subsidiaries were placed under the direct and indirect ownership of Luminex Holdings as the top-tier U.S. entity.
3. Filing Entities
The HSR Notification Form was filed by the following persons:
• Acquiring entity: Ardent Apex Holdings Inc., a Delaware corporation incorporated on March 5, 2025, with employer identification number 93-2178435. Ardent Apex is the direct parent of the Merger Sub (defined below) and will be the direct parent of Luminex Holdings following the closing of the Transaction. Ardent Apex is a wholly owned subsidiary of Ardent Fund III.
• Acquired entity: Luminex Systems Holdings Inc., filing as the acquired person pursuant to 16 C.F.R. § 803.2(a).
B. Transaction Structure
The Transaction is structured as a reverse triangular merger under the Delaware General Corporation Law (the "DGCL"), as follows:
• Ardent Apex Merger Sub Inc. (the "Merger Sub"), a Delaware corporation incorporated on March 7, 2025 (EIN: 93-2178502), was formed as a newly created, wholly owned subsidiary of Ardent Apex Holdings Inc. for the sole purpose of effectuating the merger.
• At the effective time of the merger (the "Effective Time"), Merger Sub will merge with and into Luminex Holdings, with Luminex Holdings surviving the merger as the surviving corporation (the "Surviving Corporation").
• As a result of the merger, the separate corporate existence of Merger Sub will cease, and the Surviving Corporation will become a wholly owned subsidiary of Ardent Apex Holdings Inc.
• Ardent Apex Holdings Inc. is, in turn, a wholly owned subsidiary of Ardent Capital Partners III LP, which is the UPE for HSR purposes.
The reverse triangular merger structure was selected for several reasons, including (i) preservation of Luminex Holdings' existing contractual relationships, regulatory licenses, and intellectual property registrations, (ii) facilitation of the management rollover equity arrangements described below, and (iii) tax structuring considerations analyzed by Pendleton & Associates LLP (see separate tax memorandum in the matter file).
C. Merger Consideration
The Transaction is an all-cash transaction, with the exception of certain management rollover equity arrangements as described below.
• Aggregate equity value: $2,800,000,000 on a fully diluted basis, which includes the value of all outstanding shares of Luminex Holdings common stock, in-the-money stock options, restricted stock units, and other equity awards.
• Per-share merger consideration: $20.00 per share of Luminex Holdings common stock, calculated on the basis of 140,000,000 fully diluted shares outstanding ($2,800,000,000 ÷ 140,000,000 = $20.00 per share).
• The Transaction constitutes a change of control of Luminex Holdings within the meaning of the Merger Agreement and applicable regulatory frameworks. Upon completion of the merger, Ardent Fund III will control 100% of the voting securities of the Surviving Corporation through its wholly owned subsidiary, Ardent Apex Holdings Inc.
The merger consideration is being funded through a combination of (i) equity commitments from Ardent Fund III and certain co-investment vehicles, (ii) committed debt financing under a fully committed financing letter from a syndicate led by Thackeray Securities and Greaves Bancorp, and (iii) management rollover equity. The financing structure is documented in separate memoranda in the matter file and is not material to the HSR filing analysis.
D. Merger Agreement
The definitive Agreement and Plan of Merger (the "Merger Agreement") was executed on March 24, 2025, among Ardent Apex Holdings Inc., Ardent Apex Merger Sub Inc., and Luminex Systems Holdings Inc. The Merger Agreement was negotiated on behalf of the Company by its board of directors, with the assistance of Caldwell, Raines & Sheppard LLP as legal counsel and Pinehurst Rothwell & Co. as financial advisor.
The Merger Agreement provides for an Outside Date of September 10, 2025, which may be extended by either party to December 10, 2025 if the sole condition to closing that remains unsatisfied as of the initial Outside Date is the receipt of required regulatory approvals (including, without limitation, expiration or early termination of the HSR Act waiting period, CFIUS clearance, and applicable non-U.S. competition and regulatory approvals).
The Merger Agreement conditions the obligation of each party to consummate the closing on, among other things, (i) the expiration or early termination of the waiting period under the HSR Act (or, in the event a Second Request is issued, full compliance with such Second Request and the subsequent expiration or early termination of the extended waiting period), (ii) CFIUS clearance, (iii) receipt of required non-U.S. regulatory approvals, and (iv) the absence of any order or injunction prohibiting consummation of the merger.
E. Selling Shareholders
The principal shareholders of Luminex Holdings and their expected transaction proceeds are as follows:
1. Ridgeline Growth Equity Fund II LP — a Delaware limited partnership with principal offices at 200 Clarendon Street, 52nd Floor, Boston, MA 02116. Managing Partner: Jonathan Ashford. Ridgeline holds approximately 52% of the fully diluted equity of Luminex Holdings and is expected to receive aggregate cash merger consideration of approximately $1,456,000,000 (52% × $2,800,000,000).
2. Meridian Venture Partners IV LP — a Delaware limited partnership with principal offices at 600 Montgomery Street, Suite 2800, San Francisco, CA 94111. Managing Partner: Claire Fujimoto. Meridian holds approximately 20% of the fully diluted equity of Luminex Holdings and is expected to receive aggregate cash merger consideration of approximately $560,000,000 (20% × $2,800,000,000).
3. Management and employee holders — Management and employee shareholders (including holders of vested and unvested stock options and restricted stock units) collectively hold approximately 28% of the fully diluted equity of Luminex Holdings, representing aggregate equity value of approximately $784,000,000. Of this amount, certain members of Luminex senior management have entered into rollover agreements pursuant to which they will contribute an aggregate of approximately $405,020,000 in equity value into the post-closing equity structure of Ardent Apex Holdings Inc. (the "Rollover Amount"), with the balance of approximately $378,980,000 being paid in cash at the Effective Time.
III. HSR Filing Details
A. Filing Date and Transaction Number
The HSR Notification Form was filed electronically via the FTC's efile system on March 28, 2025. The FTC assigned the filing HSR Transaction No. HSR-20250328-4192.
Both the acquiring person's and the acquired person's notification forms were submitted simultaneously on March 28, 2025. Confirmation of receipt was obtained from the FTC's Premerger Notification Office on the same date.
B. Filing Fee
The filing fee for the Transaction was calculated in accordance with the 2025 HSR Act filing fee schedule, as adjusted pursuant to Section 605 of the Departments of Commerce, Justice, and State, the Judiciary, and Related Agencies Appropriations Act, as implemented by the FTC's annual fee adjustment notice.
Based on the aggregate transaction value of $2,800,000,000, the applicable filing fee is $2,390,000. This fee corresponds to the tier for transactions valued in excess of $2 billion but not greater than $5 billion under the 2025 fee schedule.
The filing fee was paid by wire transfer on March 28, 2025, on behalf of the acquiring person, Ardent Capital Partners III LP. Payment was transmitted from the Calderwood & Harkness LLP trust account to the United States Treasury, and confirmation of wire transfer receipt has been obtained and filed in the matter file. Pursuant to the HSR Act, the filing fee is the obligation of the acquiring person.
C. Filing Persons and Contacts
The following counsel served as the designated contacts for each filing person on the HSR Notification Form:
• Acquiring person's counsel: Calderwood & Harkness LLP; Elaine Forsythe, Specialist Partner, Antitrust & Competition; 7 Times Square, New York, NY 10036; Tel: (212) 848-7200; Email: eforsythe@calderwoodharkness.com.
• Acquired person's counsel: Caldwell, Raines & Sheppard LLP; Gregory Lam, Partner, Antitrust; 51 West 52nd Street, New York, NY 10019; Tel: (212) 903-6100; Email: glam@caldwellraines.com.
Both the acquiring person's filing and the acquired person's filing were submitted simultaneously on March 28, 2025, as required under the HSR Rules. Calderwood & Harkness LLP prepared the acquiring person's filing, and Caldwell, Raines & Sheppard LLP prepared the acquired person's filing. Coordination between the two firms on cross-referenced items (including transaction description, structure chart, and certain overlapping data points) was conducted in advance of the filing date.
D. Notification Form Content Summary
The principal items of the HSR Notification Form were completed as follows:
Item 1 — Transaction Type. The filing identifies the Transaction as an acquisition of voting securities effectuated through a merger. Specifically, Ardent Apex Holdings Inc. will acquire 100% of the voting securities of Luminex Holdings by virtue of the reverse triangular merger described in Section II.B above. The Transaction is valued at $2,800,000,000 on a fully diluted basis.
Item 2 — Acquiring Person. The acquiring person is identified as Ardent Capital Partners III LP as the UPE. The filing includes all entities controlled by the UPE, including:
(a) Ardent Capital GP III LLC (the general partner of Ardent Fund III);
(b) Ardent Apex Holdings Inc. (the direct acquirer);
(c) Ardent Apex Merger Sub Inc. (the merger subsidiary);
(d) All portfolio companies of Ardent Fund III and affiliated funds under common control, including, critically, Vectis Solutions LLC, a procurement-automation SaaS provider that is a portfolio company of Ardent Capital Partners II LP. Vectis Solutions is included within the acquiring person's filing because Ardent Fund II shares a common general partner (Ardent Capital GP II LLC, which is controlled by the same managing partners, Ted Hargrove and Victoria Langford) and an overlapping investment committee with Ardent Fund III, resulting in common control for HSR purposes under 16 C.F.R. § 801.1(b).
Item 3 — Acquired Entity. The acquired entity is identified as Luminex Systems Holdings Inc. and all of its direct and indirect subsidiaries, including:
(a) Luminex Systems AG (Switzerland — parent operating company);
(b) Luminex Systems Inc. (U.S. operating subsidiary);
(c) Luminex Systems UK Ltd. (United Kingdom);
(d) Luminex Systems GmbH (Germany);
(e) Luminex Systems Pte. Ltd. (Singapore).
Item 4 — Revenue Data. The filing reports the following revenue data for Luminex Holdings and its subsidiaries for fiscal year 2024:
Revenue data for the acquiring person's controlled entities, including Vectis Solutions LLC, was reported in the acquiring person's filing as required under the HSR Rules.
Item 5 — NAICS Codes. The filing identifies the primary North American Industry Classification System (NAICS) codes applicable to Luminex Holdings' operations. The primary code reported is NAICS 511210 — Software Publishers, which encompasses the Company's enterprise SaaS, procurement automation, and supply-chain analytics software products. Additional NAICS codes were reported as applicable to the Company's professional services and implementation consulting activities.
Item 6 — Overlap NAICS Codes. The filing flags NAICS 511210 (Software Publishers) as an overlap code, reflecting the fact that both Luminex Holdings and Vectis Solutions LLC (an Ardent-controlled portfolio company included in the acquiring person's filing) operate in the procurement-automation SaaS segment within the broader Software Publishers classification. This overlap is the principal competitive concern identified in our antitrust analysis and is discussed in detail in Section V below.
Item 7 — Prior Acquisitions. The filing includes information regarding prior acquisitions by Ardent Capital Partners III LP and affiliated funds during the relevant lookback period, as required by the HSR Rules. Specific details of prior acquisitions were compiled in a separate schedule annexed to the Notification Form.
Item 8 — Minority Holdings. No material minority holdings were identified outside the existing Ardent portfolio company structure. Neither the acquiring person nor the acquired person holds minority positions in competitors that are material to the competitive analysis of this Transaction.
E. Waiting Period
The initial 30-calendar-day waiting period under the HSR Act commenced upon the filing of the HSR Notification Form on March 28, 2025. Pursuant to 15 U.S.C. § 18a(b)(1)(B), the initial waiting period is calculated as 30 calendar days from the date of filing.
Accordingly, the initial waiting period is scheduled to expire on April 27, 2025 (30 calendar days from March 28, 2025).
As described in Section VI below, the engagement team anticipates that the FTC will issue a Second Request prior to the expiration of the initial waiting period. If a Second Request is issued, the waiting period is extended and does not expire until 30 days after the date on which the acquiring person has substantially complied with the Second Request, unless the reviewing agency grants early termination of the extended waiting period.
The Merger Agreement conditions the obligation of the parties to consummate the closing on the expiration or early termination of the HSR Act waiting period, or, in the event a Second Request is issued, substantial compliance with the Second Request and the subsequent expiration or early termination of the extended waiting period.
IV. Agency Assignment
On April 2, 2025, the engagement team received notification that the Transaction was cleared to the Federal Trade Commission (FTC) for review. The DOJ/FTC clearance allocation process, pursuant to the inter-agency agreement governing the division of merger review responsibilities, resulted in the FTC assuming jurisdiction over the Transaction.
The FTC's assumption of review authority over this Transaction is consistent with the Commission's established jurisdiction over technology and software industry transactions. The FTC has historically exercised primary responsibility for reviewing mergers and acquisitions in the enterprise software, SaaS, and related technology sectors, and has maintained a dedicated team of attorneys and economists within its Bureau of Competition with expertise in these markets.
We expect the Bureau of Competition to be the primary FTC bureau responsible for conducting the substantive review of the Transaction. Based on prior transactions in the enterprise software sector, we anticipate that the review will be staffed by attorneys in the Mergers I or Mergers IV division of the Bureau of Competition, with economic analysis support from the Bureau of Economics. We will update this memorandum once the identity of the assigned FTC staff attorneys and supervisory personnel has been confirmed.
The assignment to the FTC (rather than the DOJ Antitrust Division) is a relevant consideration for purposes of Second Request preparation and strategy, as the FTC's procedural practices with respect to Second Requests, timing agreements, and remedial negotiations differ in certain respects from those of the DOJ. These differences are addressed in the separately filed Second Request Preparation Memorandum.
V. Relevant Market Analysis
A. Product Market Definition
1. Primary Product Market: Procurement-Automation SaaS
The engagement team has identified the primary relevant product market as procurement-automation SaaS — that is, cloud-based software-as-a-service solutions that enable enterprise customers to automate and manage procurement processes, including sourcing, supplier management, purchase order generation, invoice processing, contract lifecycle management, and spend analytics.
This product market definition reflects the manner in which Luminex Holdings and Vectis Solutions LLC compete against each other and against other vendors for enterprise procurement software customers. Both companies offer cloud-native SaaS platforms marketed to mid-market and large enterprise customers, with subscription-based pricing models and annual recurring revenue streams. The functional overlap between the two companies' product offerings is concentrated in the procurement-automation layer of enterprise software.
Luminex Holdings' core product is "Luminex One", a cloud-based enterprise resource planning, procurement automation, and supply-chain analytics SaaS platform. Luminex One is a comprehensive suite that includes modules for procurement automation, supply-chain visibility, financial management, and analytics, but its procurement-automation module is the core competitive offering and the primary driver of customer acquisition and revenue.
Vectis Solutions LLC is a procurement SaaS provider that develops and markets a cloud-based procurement platform focused on sourcing automation, supplier relationship management, and procurement analytics for mid-market enterprise customers. Vectis Solutions is a Delaware limited liability company headquartered at 4000 Shoreline Court, Suite 300, South San Francisco, CA 94080. The company's CEO is Michael Parekh, and its employer identification number is 82-4910337. Vectis Solutions reported total revenue of approximately $68,000,000 for fiscal year 2024.
Vectis Solutions is a portfolio company of Ardent Capital Partners II LP ("Ardent Fund II"), a prior vintage fund in the Ardent Capital platform. Because Ardent Fund II shares a common general partner and overlapping investment committee with Ardent Fund III, Vectis Solutions is deemed to be under the common control of the acquiring person's UPE for purposes of the HSR Act and, accordingly, is included in the acquiring person's filing as part of the acquiring person's controlled entity structure. Although Vectis Solutions is not being acquired in the Transaction, the competitive overlap between Vectis Solutions and Luminex Holdings is the central antitrust issue raised by the Proposed Acquisition: following the closing, both Luminex and Vectis Solutions will be under common Ardent control, and the combined entity will hold a significant share of the procurement-automation SaaS market.
2. Broader Product Market Alternative: Enterprise Resource Planning (ERP) SaaS
As an alternative or broader product market definition, the engagement team has considered the market for enterprise resource planning (ERP) SaaS, which encompasses broader software suites that include not only procurement modules but also financial management, human capital management, supply-chain management, manufacturing execution, and related functionality.
Under this broader market definition, Luminex Holdings' combined market share (together with Vectis Solutions) would be significantly smaller, as the ERP SaaS market includes major platforms such as Harborline Software Cloud, Ridgeline Industries Cloud ERP, Microsoft Dynamics 365, Ashbury & Co., and other large-scale enterprise software vendors. The broader ERP SaaS market is substantially larger and less concentrated than the narrower procurement-automation SaaS segment.
However, for purposes of this analysis and our assessment of the FTC's likely approach, we believe the FTC is more likely to define the relevant product market as the narrower procurement-automation SaaS market, consistent with the Commission's practice of defining product markets at a level of specificity that reflects the actual competitive dynamics and reasonable substitutability from the perspective of customers. Enterprise customers seeking a specialized procurement-automation solution may not view a full-suite ERP platform as a close substitute, and vice versa, which supports the narrower market definition.
B. Geographic Market Definition
The relevant geographic market for the procurement-automation SaaS product market is worldwide, with particular focus on the United States as the single largest national market for both Luminex and Vectis Solutions.
Luminex Holdings derives its revenue from the following geographic regions:
Luminex Holdings' largest single national market is the United States, accounting for approximately 40% of total revenue, or $194,800,000 in fiscal year 2024. The Company's strong presence in the DACH region reflects the origins of Luminex Systems AG as a Swiss/German enterprise software company.
Vectis Solutions LLC is primarily U.S.-based, with the vast majority of its $68,000,000 in fiscal year 2024 revenue derived from U.S. customers. Vectis Solutions maintains a small but growing European presence through its German subsidiary, Vectis GmbH, which reported approximately €12,000,000 in German revenue in 2024.
For purposes of the FTC's analysis, we anticipate that the Commission will evaluate the competitive effects of the Transaction in both a worldwide market and a U.S.-specific market. The competitive overlap between Luminex and Vectis Solutions is most pronounced in the United States, where both companies actively compete for enterprise procurement software customers.
C. Market Share and Competitive Overlap
Based on the engagement team's preliminary analysis of publicly available market data, industry analyst reports, and information provided by the Client, the estimated market shares in the procurement-automation SaaS product market are as follows:
The combined post-acquisition market share of approximately 25% in a reasonably defined procurement-automation SaaS market raises potential competitive concerns under both the HHI concentration framework and the substantive standards set forth in the 2023 Merger Guidelines jointly issued by the FTC and DOJ on December 18, 2023.
It is important to reiterate that Vectis Solutions LLC is not being acquired in this Transaction. However, because Vectis Solutions is controlled by Ardent Capital (through Ardent Fund II, which shares a common general partner and overlapping investment committee with Ardent Fund III), Vectis Solutions is included within the acquiring person's entity structure for HSR purposes. The practical effect is that, following the closing of the Transaction, both Luminex Holdings and Vectis Solutions will be under the common control of the Ardent Capital platform, and the FTC will evaluate the competitive effects of the Transaction based on the combined market position of both entities.
The competitive overlap between Luminex and Vectis Solutions constitutes the primary antitrust concern raised by the Proposed Acquisition. Both companies offer cloud-based procurement SaaS solutions to enterprise customers, and customers of one platform could, in principle, consider switching to the other as an alternative provider. The degree of head-to-head competition between Luminex and Vectis Solutions in specific customer segments, RFP processes, and product categories will be a central focus of any FTC investigation.
Additional Competitor Landscape. Other significant providers in the procurement-automation SaaS space include, but are not limited to, Pemberton & Co. (now a Ostrander Equity Partners portfolio company), Ostrander Industries, Brightwater Technologies, Meridian Corporation, Cobalt Ridge Holdings, Halcyon Holdings, and Cascade Partners LLC. A comprehensive competitive landscape analysis, including estimated market shares for each of these competitors, is being developed as part of the competitive analysis workstream and will be documented in a separate memorandum. This analysis will be critical to the preparation of the engagement team's position in any Second Request response or FTC investigation.
D. HHI and Concentration Analysis
The Herfindahl-Hirschman Index (HHI) is the standard measure of market concentration used by the FTC and DOJ in evaluating the competitive effects of mergers and acquisitions. The HHI is calculated by summing the squares of the market shares of all firms in the relevant market.
Pre-Merger HHI. The pre-merger HHI in the procurement-automation SaaS market is currently being calculated based on comprehensive market share data for all significant competitors. Preliminary estimates suggest that the procurement-automation SaaS market is moderately concentrated prior to the Transaction, with a pre-merger HHI that may be in the range of 1,500 to 2,200, depending on the specific market definition and the allocation of market shares among fringe competitors.
Post-Merger HHI Increase. The estimated increase in HHI resulting from the Transaction is calculated as follows:
ΔHHI = 2 × (Luminex market share) × (Vectis market share)
ΔHHI = 2 × 18 × 7 = 252 HHI points
An HHI increase of approximately 252 points is significant under the analytical framework set forth in the 2023 Merger Guidelines. Under those Guidelines:
(a) A transaction that increases the HHI by more than 100 points in a market with a post-merger HHI above 1,800 is presumed to be likely to enhance market power and is therefore subject to heightened scrutiny.
(b) A transaction that results in a combined firm with a market share exceeding 30% is independently presumed to be likely to enhance market power, regardless of the HHI level.
In this case, the estimated ΔHHI of 252 points exceeds the 100-point threshold that triggers the structural presumption of competitive harm in concentrated markets. The combined market share of approximately 25% approaches but does not exceed the 30% threshold that independently triggers the market-share presumption. Taken together, these metrics strongly suggest that the FTC will conduct a thorough investigation of the Transaction's competitive effects in the procurement-automation SaaS market.
We note that the precise HHI calculations will depend on the final market share data for all competitors, which is being developed through the competitive analysis workstream. These calculations will be refined as additional data becomes available and will be presented in the context of any Second Request response or advocacy presentation to the FTC.
E. Vertical Considerations
The engagement team has conducted a preliminary assessment of potential vertical effects arising from the Transaction. Based on our current analysis, we have identified limited vertical overlap between the Luminex and Ardent entity structures. Luminex operates primarily as a horizontal SaaS provider, offering its platform directly to enterprise end-users on a subscription basis. Luminex does not operate as a supplier of inputs to competing SaaS platforms, nor does it control critical distribution channels, data assets, or infrastructure that would give rise to vertical foreclosure concerns.
Similarly, no significant vertical integration concerns have been identified with respect to the other Ardent portfolio companies. While the Ardent platform includes investments in various enterprise technology and financial infrastructure companies, none of these portfolio companies have been identified as operating at a different level of the procurement-automation SaaS supply chain in a manner that would create vertical foreclosure or raising-rivals'-costs concerns.
We do not anticipate that the FTC will devote significant investigative resources to vertical theories of harm in connection with this Transaction. However, the engagement team will continue to monitor this issue and will update this assessment if additional information becomes available.
VI. Anticipated Second Request
A. Basis for Anticipation
Based on the competitive overlap analysis set forth in Section V above, the engagement team expects that the FTC will issue a Second Request in connection with the Transaction. This expectation is based on the following considerations:
First, the combined approximately 25% market share in the procurement-automation SaaS market resulting from the common Ardent control of Luminex Holdings and Vectis Solutions is expected to draw FTC scrutiny. While the combined share does not exceed the 30% threshold that independently triggers the structural presumption under the 2023 Merger Guidelines, it is sufficiently significant — particularly in a moderately concentrated market — to warrant a thorough investigation by the Commission.
Second, the estimated HHI increase of approximately 252 points exceeds the 100-point threshold that, in markets with a post-merger HHI above 1,800, triggers a presumption that the transaction is likely to enhance market power under the 2023 Merger Guidelines. Even if the precise pre-merger HHI falls below 1,800 under certain market definitions, the magnitude of the HHI delta is sufficient to raise concerns that will likely prompt the FTC to seek additional information before allowing the Transaction to proceed.
Third, the FTC has demonstrated heightened enforcement interest in technology-sector consolidation, particularly in SaaS markets, in recent years. The Commission has challenged or investigated several transactions in the enterprise software and cloud computing sectors, reflecting a broader enforcement posture that is skeptical of consolidation among competing SaaS platforms. This enforcement environment increases the likelihood that the FTC will issue a Second Request to conduct a full-phase investigation of the Transaction.
Fourth, the competitive overlap between Luminex and Vectis Solutions — both of which are procurement-automation SaaS providers that will be under common Ardent control following the closing — is the primary basis for the anticipated Second Request. The FTC is expected to investigate the extent to which Luminex and Vectis Solutions compete head-to-head for the same customers, the degree to which customers view the two platforms as substitutes, and the potential for the combined entity to exercise market power through coordinated pricing, reduced innovation, or other competitive effects.
Based on the foregoing analysis, the engagement team anticipates that the Second Request will be issued on or about April 25, 2025, approximately two days prior to the expiration of the initial 30-day waiting period on April 27, 2025. This timing is consistent with the FTC's typical practice of issuing Second Requests near the end of the initial waiting period, after the staff has had an opportunity to conduct a preliminary review of the filings and associated market data.
B. Second Request Preparation
In anticipation of the Second Request, the engagement team has commenced preparation activities as documented in a separate internal memorandum prepared by Elaine Forsythe (the "Second Request Preparation Memorandum," filed separately in the matter file). The Second Request Preparation Memorandum addresses the following key workstreams:
1. Document-Hold and Custodian Identification. Litigation hold notices have been prepared and will be issued to all anticipated custodians promptly upon receipt of the Second Request (or, in the case of key custodians, in advance of receipt). A preliminary custodian list has been developed in coordination with the Client and the Company.
2. Data Collection Plan. A plan for the collection, processing, and production of responsive documents and data (including electronically stored information, structured data, and business records) is under development. The plan addresses document collection from Ardent Capital investment professionals, Luminex senior management, and Vectis Solutions management and employees.
3. Timeline for Compliance. A preliminary timeline for substantial compliance with a Second Request has been developed, taking into account the volume of anticipated document production, the number of custodians, and the complexity of the data collection process. The timeline contemplates a compliance period of approximately 60 to 90 days from the date of Second Request issuance, subject to negotiation with the FTC staff through a timing agreement.
4. Coordination with Client and Portfolio Company. The engagement team is coordinating Second Request preparation with the following individuals:
• Ardent Capital Partners: Ted Hargrove (Co-Founder & Managing Partner), Victoria Langford (Co-Founder & Managing Partner), and David Ng (Partner, Deal Team Lead for the Transaction);
• Vectis Solutions LLC: Michael Parekh (CEO), as the principal executive responsible for coordinating Vectis Solutions' document collection and response obligations under the Second Request.
5. Anticipated Custodians. The preliminary list of anticipated custodians for the Second Request includes, but is not limited to:
• Key Ardent Capital investment professionals involved in the Transaction and/or the management of Vectis Solutions;
• Luminex senior management, including Dr. Stefan Kessler (Chief Executive Officer), Annelise Gruber (Chief Financial Officer), and Dr. Markus Vogt (Chief Technology Officer);
• Vectis Solutions management, including Michael Parekh (CEO) and other senior executives to be identified.
The Second Request Preparation Memorandum is being updated on a rolling basis as the engagement team refines the custodian list, data collection plan, and compliance timeline.
C. Potential Remedies Considerations
A separate privileged memorandum analyzing potential divestiture and behavioral remedy scenarios is being prepared by Elaine Forsythe and will be filed in the matter file under the title "Remedies / Divestiture Analysis Memorandum" (forthcoming). That memorandum will address, among other things, the following issues:
(a) The likelihood that the FTC will require a structural remedy (divestiture) as a condition to clearance of the Transaction, based on the competitive overlap analysis and the Commission's recent enforcement posture;
(b) The range of potential divestiture packages that could be offered or negotiated, including the divestiture of Vectis Solutions LLC or a subset of its assets;
(c) The feasibility and competitive implications of behavioral remedies (e.g., firewalls, non-discrimination commitments, or interoperability requirements), and the FTC's historically skeptical posture toward behavioral remedies in horizontal merger cases;
(d) The implications of any required remedy for the economics of the Transaction and the investment thesis of Ardent Fund III.
As a high-level preliminary note for purposes of this memorandum: if the FTC ultimately requires a remedy as a condition to clearance, the most likely path would involve the divestiture of Vectis Solutions LLC (an Ardent Fund II portfolio company with $68 million in 2024 revenue) rather than the divestiture of any Luminex Holdings business unit. This assessment is based on the relative size differential between the two companies (Luminex at $487 million in total revenue versus Vectis at $68 million), the deal economics (the Transaction is a $2.8 billion acquisition of Luminex, whereas Vectis Solutions represents a substantially smaller investment in a prior vintage fund), and the general principle that divestiture of the smaller overlapping asset is the least disruptive remedy to the parties' commercial objectives while fully addressing the competitive concerns identified by the reviewing agency.
This analysis is preliminary and subject to revision based on the FTC's specific concerns, the scope of any Second Request investigation, and the negotiations with FTC staff. The Remedies / Divestiture Analysis Memorandum will address these issues in comprehensive detail.
VII. Other Pending Regulatory Filings
The Transaction is subject to multiple regulatory approvals in addition to HSR Act clearance. The following parallel regulatory filings have been made or are in process, each of which is documented in separate memoranda maintained in the matter file:
1. CFIUS Voluntary Joint Notice. A voluntary joint notice was filed with the Committee on Foreign Investment in the United States ("CFIUS") on April 4, 2025, under Tracking No. CFIUS-2025-0087. The CFIUS filing was made in light of Luminex Holdings' U.S. government and critical infrastructure customer base, as well as the involvement of Luminex Systems AG (a Swiss entity) in the Transaction structure. The initial 45-day CFIUS review period is expected to expire on May 19, 2025. A separate CFIUS memorandum has been prepared by the engagement team's national security and CFIUS practice group.
2. Swiss FINMA/SECO Notification. A notification was filed with the Swiss Financial Market Supervisory Authority (FINMA) and the State Secretariat for Economic Affairs (SECO) on April 7, 2025, under File No. 32-0973. The filing is currently in Phase I review. This notification was required in light of the change of control of Luminex Systems AG, the Swiss parent operating company within the Luminex group. A separate memorandum addressing the Swiss regulatory process has been prepared by the engagement team's Swiss counsel.
3. Bundeskartellamt Filing (Germany). A merger notification was filed with the German Federal Cartel Office (Bundeskartellamt) on April 9, 2025, under File No. B6-34/25. The filing is currently in Phase I review, with the standard one-month review period applicable to Phase I proceedings. The filing was required because the Transaction meets the jurisdictional thresholds under Section 35 of the German Act Against Restraints of Competition (Gesetz gegen Wettbewerbsbeschränkungen, "GWB"): the combined worldwide turnover of the parties exceeds €500 million, and the domestic (German) turnover of the acquired group (Luminex Systems GmbH reported €67,000,000 in German revenue in 2024) and the Ardent-controlled overlap entity (Vectis GmbH reported €12,000,000 in German revenue in 2024) each exceed the €25 million domestic threshold. A separate memorandum addressing the German competition filing has been prepared by the engagement team's German competition counsel.
4. EU Foreign Subsidies Regulation (FSR) Notification. A notification under the EU Foreign Subsidies Regulation (Regulation (EU) 2022/2560) was filed with the European Commission on April 11, 2025, under Case No. FSR.M.2025-0412. The notification is currently in the preliminary review phase, which has a duration of 25 business days from the date of filing. The FSR notification was required because the Transaction meets the thresholds for mandatory notification: the aggregate turnover of the acquired entity in the EU exceeds €500 million, and the aggregate foreign financial contributions to the parties exceed the applicable threshold. A separate memorandum addressing the FSR filing has been prepared by the engagement team.
The engagement team maintains a Regulatory Conditions & Timetable Tracker that provides a consolidated overview of all regulatory filings, review periods, key dates, and status updates for the Transaction. This tracker is updated on a weekly basis and is distributed to the deal team, the Client, and co-counsel. Cross-reference to the Regulatory Conditions & Timetable Tracker should be made for the most current information on the status of each parallel regulatory filing.
VIII. Key Timing Considerations
The following timeline summarizes the key regulatory and contractual milestones for the Transaction:
HSR Initial Waiting Period. The initial 30-calendar-day waiting period commenced upon the filing of the HSR Notification Form on March 28, 2025, and is scheduled to expire on April 27, 2025.
Anticipated Second Request. As discussed in Section VI above, the engagement team anticipates that the FTC will issue a Second Request on or about April 25, 2025, approximately two days prior to the expiration of the initial waiting period. If a Second Request is issued, the initial waiting period is superseded, and a new waiting period commences that does not expire until 30 days after the acquiring person certifies substantial compliance with the Second Request (unless the FTC grants early termination of the extended waiting period or withdraws the Second Request).
Merger Agreement Outside Date. The Merger Agreement provides for an Outside Date of September 10, 2025, which may be extended by either party to December 10, 2025 if the sole unsatisfied closing condition as of the initial Outside Date is the receipt of required regulatory approvals. This extension mechanism provides the parties with additional time to complete the regulatory review process, including Second Request compliance and any remedial negotiations with the FTC, without triggering termination rights under the Merger Agreement.
Target Estimated Closing. Based on the engagement team's current assessment of the regulatory timeline, the target estimated closing for the Transaction is Q3 2025 (July – August 2025), subject to the pace of the FTC's review, the Second Request compliance timeline, and the resolution of any parallel regulatory proceedings. This estimate assumes that (i) a Second Request is issued in late April 2025, (ii) the acquiring person achieves substantial compliance within approximately 60 to 90 days of issuance, and (iii) the FTC staff concludes its investigation and either clears the Transaction or reaches an agreement on remedies within 30 to 60 days after compliance.
FTC Timing Agreement. The engagement team intends to negotiate a timing agreement with the FTC staff governing the schedule for Second Request compliance, the FTC's investigative process, and the procedures for any post-compliance discussions. A draft timing agreement letter is under preparation by Elaine Forsythe and will be circulated for review by the deal team prior to submission to the FTC. The timing agreement memorandum and draft letter are filed separately in the matter file.
Pull-and-Refile Strategy. The engagement team has also considered the potential utility of a pull-and-refile strategy — i.e., the voluntary withdrawal and refiling of the HSR Notification Form in order to reset the 30-day waiting period — should circumstances warrant. A pull-and-refile may be appropriate if, for example, the FTC staff indicates a willingness to clear the Transaction without a Second Request but requires additional time beyond the initial waiting period to complete its review. The engagement team will evaluate the advisability of this strategy based on developments during the initial waiting period and in consultation with the Client.
IX. Advisors and Coordination
The following professional advisors are engaged in connection with the Transaction and are coordinating on regulatory, competitive, and transactional matters:
Buyer's Antitrust Counsel:
Calderwood & Harkness LLP 7 Times Square, New York, NY 10036 Elaine Forsythe, Specialist Partner, Antitrust & Competition Tel: (212) 848-7200
Calderwood & Harkness LLP serves as lead antitrust counsel to Ardent Capital Partners III LP and Ardent Apex Holdings Inc. in connection with the HSR filing, FTC review, Second Request preparation and compliance, and all related antitrust and competition matters (including parallel non-U.S. filings, in coordination with local counsel).
Seller's Antitrust Counsel:
Caldwell, Raines & Sheppard LLP 51 West 52nd Street, New York, NY 10019 Gregory Lam, Partner, Antitrust Tel: (212) 903-6100
Caldwell, Raines & Sheppard LLP serves as antitrust counsel to Luminex Systems Holdings Inc. in connection with the HSR filing and regulatory review process.
Buyer's Financial Advisor:
Whitfield Partners LLC Christopher Brennan, Managing Director
Whitfield Partners LLC is serving as financial advisor to Ardent Capital Partners III LP in connection with the Transaction. Whitfield Partners is providing financial and strategic advisory services and is coordinating with the engagement team on market data, competitive positioning, and economic analysis relevant to the antitrust review.
Seller's Financial Advisor:
Pinehurst Rothwell & Co. Samantha Delacroix, Managing Director
Pinehurst Rothwell & Co. is serving as financial advisor to Luminex Systems Holdings Inc. and its board of directors in connection with the Transaction.
Buyer's Accounting / Tax Advisor:
Pendleton & Associates LLP Richard Chow, Partner
Pendleton & Associates LLP is providing accounting and tax advisory services to Ardent Capital Partners III LP and is also supporting the engagement team with economic and market data relevant to the HSR filing and competition analysis, including market sizing, revenue verification, and financial modeling.
Inter-Advisor Coordination. The engagement team has established a regular coordination cadence among the professional advisors to ensure alignment on competitive market data, economic analysis, and document production preparation. Weekly regulatory update calls are being held among Calderwood & Harkness, Caldwell, Raines & Sheppard, and the respective financial advisors. All inter-firm communications regarding competitive analysis and regulatory strategy are conducted under the common interest privilege and are documented accordingly.
X. Document Retention and Privilege
All internal memoranda, analyses, communications, draft filings, and related work product regarding the HSR filing, competitive analysis, Second Request preparation, remedies analysis, and regulatory strategy for the Transaction have been prepared by and at the direction of counsel at Calderwood & Harkness LLP and are protected by the attorney-client privilege and the attorney work product doctrine. These materials reflect the mental impressions, conclusions, opinions, and legal theories of counsel and were prepared in anticipation of regulatory proceedings and potential litigation with the FTC.
The following document retention practices are in effect for this matter:
1. Filing Materials. All materials related to the HSR filing, including the completed HSR Notification Forms (both acquiring person and acquired person forms), schedules, exhibits, attachments, and supporting documentation, are maintained in the Calderwood & Harkness matter file under Matter No. 1001-00004.
2. Fee Payment Records. Records of the filing fee wire transfer, including wire confirmation, bank statements, and fee calculation worksheets, are maintained in the matter file.
3. Regulatory Workstream Subfolder. Copies of the filed HSR Notification Forms (both acquiring and acquired person forms), FTC correspondence, agency assignment notifications, and all related regulatory documents are maintained in a dedicated regulatory workstream subfolder within the matter file.